Bedford Laboratories®24 April 2014
July 16, 2009

Bedford Laboratories Begins Shipping Ceftriaxone for Injection USP

Bedford Laboratories™, a division of Ben Venue Laboratories, Inc. announced FDA approval to begin shipping Ceftriaxone for Injection USP. This product is AP rated and is equivalent to Rocephin® by Roche. Ceftriaxone is a semisynthetic, broad-spectrum antibiotic used to treat several types of infections caused by susceptible bacteria.

Bedford Laboratories will supply Ceftriaxone for Injection USP as a sterile crystalline powder in glass vials in the following presentations: Single-dose vials containing either 250mg, 500mg, 1g, or 2g equivalent of ceftriaxone packaged in cartons containing 10 vials and a pharmacy bulk vial containing the equivalent of 10g ceftriaxone packaged in cartons containing 1 vial.

Prescribing information is available upon request from Bedford Laboratories' professional services department at 1-800-521-5169, or from the company's website, www.bedfordlabs.com.

Rocephin® is a registered trademark of Hoffmann-La Roche, Inc.

Media Contact

  • Please send media or public relations inquiries to Ben Venue Laboratories care of our Media/PR email.